Table 4. Pooled ORs with 95% CIs for the association between MNS16A and cancer risk by omitting each article in sensitivity analysis.
| First author | Year | Genetic model | ORs (95%CI) | P a | P for | I2 |
| heterogeneity | ||||||
| Wang [14] | 2003 | LS vs. LL | 1.16 (1.07–1.27) | 0.000 | 0.136 | 31.8% |
| Dominant | 1.19 (1.07–1.33) | 0.001 | 0.097 | 36.7% | ||
| Carpentier [16] | 2007 | LS vs. LL | 1.14 (1.01–1.29) | 0.028 | 0.091 | 38.8% |
| Dominant | 1.15 (1.02–1.30) | 0.023 | 0.053 | 44.9% | ||
| Wang [19] | 2008 | LS vs. LL | 1.12 (1.03–1.23) | 0.009 | 0.224 | 22.3% |
| Dominant | 1.15 (1.06–1.25) | 0.001 | 0.122 | 33.5% | ||
| Andersson [15] | 2009 | LS vs. LL | 1.15 (0.97–1.36) | 0.103 | 0.034 | 50.3% |
| Dominant | 1.15 (0.98–1.37) | 0.187 | 0.023 | 53.4% | ||
| Jin [18] | 2010 | LS vs. LL | 1.16 (1.03–1.31) | 0.017 | 0.076 | 39.8% |
| Dominant | 1.18 (1.04–1.33) | 0.009 | 0.044 | 45.3% | ||
| Hofer [21] | 2011 | LS vs. LL | 1.15 (1.02–1.29) | 0.019 | 0.077 | 39.5% |
| Dominant | 1.18 (1.04–1.32) | 0.007 | 0.044 | 45.3% | ||
| Zhang [22] | 2011 | LS vs. LL | 1.20 (1.10–1.31) | 0.000 | 0.656 | 0.00% |
| Dominant | 1.23 (1.13–1.33) | 0.000 | 0.719 | 0.00% | ||
| Chang [17] | 2011 | LS vs. LL | 1.15 (1.03–1.29) | 0.016 | 0.075 | 39.8% |
| Dominant | 1.18 (1.05–1.32) | 0.006 | 0.044 | 45.3% | ||
| Zagouri [20] | 2012 | LS vs. LL | 1.15 (1.02–1.28) | 0.018 | 0.097 | 36.7% |
| Dominant | 1.17 (1.04–1.31) | 0.008 | 0.046 | 45.0% | ||
| Hofer [23] | 2013 | LS vs. LL | 1.15 (1.02–1.31) | 0.027 | 0.074 | 40.0% |
| Dominant | 1.17 (1.03–1.33) | 0.015 | 0.044 | 45.3% |
a
P value was calculated by the Z test.